EU Regulators Push For Better Support For Sponsors On Using Animal Study Alternatives

The European Medicines Agency’s innovation network has recommended how the EU’s regulatory framework could be updated to support drug developers in using new approach methodologies, which are drug testing methods that reduce or replace animal studies.

Sponsors need clarity on when they can use alternatives to animal testing in drug development (Shutterstock)

More from Clinical Trials

More from Geography